Concepedia

Use of phosphate-binding agents is associated with a lower risk of mortality

Jorge B. Cannata‐Andía, José Luis Fernández Martín, Francesco Locatelli, Gérard M. London, José Luis Górriz, Jürgen Floege, Markus Ketteler, Aníbal Ferreira, Adrian Covic, Dimitrios Memmos,

Kidney International · 2013 · 157 citations · 34 references

DOIFull text

Open access

Concepts

References

34

KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD)

Alison M. MacLeod · Kidney International · 2009 · 2.2K citations

, , +16

Fibroblast Growth Factor 23 and Mortality among Patients Undergoing Hemodialysis

Orlando M. Gutiérrez, Michael Mannstadt, Tamara Isakova et al. · New England Journal of Medicine · 2008 · 1.7K citations · Full text

, , +17

Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients

Glenn M. Chertow, Steven K. Burke, Paolo Raggi et al. · Kidney International · 2002 · 1.5K citations · Full text

, , +14

Survival of Patients Undergoing Hemodialysis with Paricalcitol or Calcitriol Therapy

Ming Teng, Myles Wolf, Edmund G. Lowrie et al. · New England Journal of Medicine · 2003 · 926 citations · Full text

, , +17

Mortality effect of coronary calcification and phosphate binder choice in incident hemodialysis patients

Geoffrey A. Block, Paolo Raggi, Antonio Bellasi et al. · Kidney International · 2007 · 791 citations · Full text

, , +13